Xiongbin Lu

22PUBLICATIONS
103CO-AUTHORS
Molecular targetsHaematological tumoursMechanobiologyPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jun 24, 2026
Retraction Note: Carbon nano-onion-mediated dual targeting of P-selectin and P-glycoprotein to overcome cancer drug resistance.

|Feb 26, 2026
Tumor-associated CD19<sup>+</sup> macrophages induce immunosuppressive microenvironment in hepatocellular carcinoma.

Junli Wang, Wanyue Cao, Jinyan Huang

|Oct 20, 2025
HNRNPA2B1 Orchestrates Immune Evasion in Colorectal Cancer by Rewiring Tumor-Immune Cell Interactions and Suppressing CD8+ T-cell Infiltration.

Chuwei Liu, Heng Liang, Peipei Wang

|Sep 26, 2025
STK11 coordinates IL-4 signaling with metabolic reprogramming to control M2 macrophage polarization and antitumor immunity.

Jing Yang, Naresh Singh, Chengxian Xu

|Aug 22, 2025
Targeting spermine metabolism to overcome immunotherapy resistance in pancreatic cancer.

Hanshen Yang, Xiaozhen Zhang, Sirui Zhang

|Aug 22, 2025
Reprogramming intratumoral T<sub>reg</sub> cells by morpholino-mediated splicing of FOXP3 for cancer immunotherapy.

Yujing Li, Naresh Singh, Chuanpeng Dong

Pageof 4

Frequent Collaborators

5 joint publications

Xiaoming He

5 joint publications

Jun Wan

5 joint publications

Xinna Zhang

3 joint publications

Tao Yu